Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | AMGN | GILD | VRTX | BIIB |
| Company | Cara Therapeutics | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7900 | 300.12 | 65.57 | 413.33 | 218.00 |
| High | 0.8000 | 306.11 | 65.61 | 425.65 | 220.53 |
| Low | 0.7400 | 298.89 | 64.97 | 412.12 | 217.00 |
| Last | 0.7400 | 304.55 | 65.07 | 422.95 | 220.78 |
| Change | -0.0522 | +4.25 | -0.39 | +12.71 | +1.86 |
| % Change | -6.59% | +1.42% | -0.60% | +3.10% | +0.85% |
| Volume | 122,969 | 1,080,246 | 1,767,573 | 829,442 | 233,730 |
| 20-Day Average Volume | 279,496 | 2,775,892 | 7,286,336 | 1,090,222 | 1,342,327 |
| Previous Close | 0.7922 | 300.30 | 65.46 | 410.24 | 218.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7355 | 277.14 | 66.31 | 399.72 | 205.48 |
| 20-Day Raw Stochastic | 55.54% | 69.40% | 15.65% | 81.94% | 93.66% |
| 20-Day Relative Strength | 47.35% | 64.49% | 33.21% | 60.30% | 57.84% |
| Weighted Alpha | -72.05 | +30.13 | -20.80 | +21.58 | -26.55 |
| Today's Opinion | 56% Sell | 56% Buy | 100% Sell | 56% Buy | 56% Sell |
| Previous Opinion | 56% Sell | 40% Buy | 100% Sell | 32% Buy | 56% Sell |
| Last Month's Opinion | 32% Sell | 8% Sell | 100% Sell | 24% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.14% since 05/01/24 | +9.48% since 05/01/24 | -0.68% since 05/01/24 | +4.29% since 05/01/24 | +1.93% since 05/01/24 |
| Low | 0.7400 on 05/08/24 | 274.90 on 05/02/24 | 64.33 on 05/03/24 | 394.03 on 05/07/24 | 213.11 on 05/03/24 |
| High | 0.8315 on 05/06/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 425.65 on 05/08/24 | 222.40 on 05/06/24 |
| 1-Month | |||||
| %Chg | -10.07% since 04/08/24 | +12.80% since 04/08/24 | -6.27% since 04/08/24 | +3.75% since 04/08/24 | +7.49% since 04/08/24 |
| Low | 0.6311 on 04/16/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.8592 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 425.65 on 05/08/24 | 222.40 on 05/06/24 |
| 3-Month | |||||
| %Chg | +42.74% since 02/08/24 | +2.99% since 02/08/24 | -11.84% since 02/08/24 | -0.87% since 02/08/24 | -8.32% since 02/08/24 |
| Low | 0.5200 on 02/13/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.1500 on 03/04/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | -37.61% since 11/08/23 | +11.12% since 11/08/23 | -16.48% since 11/08/23 | +11.26% since 11/08/23 | -4.91% since 11/08/23 |
| Low | 0.5000 on 01/25/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 1.3100 on 12/15/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 43,307 | 161,091,424 | 81,502,736 | 106,030,224 | 31,874,096 |
| Shares Outstanding, K | 54,667 | 536,435 | 1,245,077 | 258,459 | 145,597 |
| Annual Sales | 20,970,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -118,510,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 3,000,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 | 2,290,500,000 |
| Last Quarter Net Income | -32,340,000 | -113,000,000 | -4,170,000,000 | 968,800,000 | 393,400,000 |
| 60-Month Beta | 0.74 | 0.60 | 0.22 | 0.39 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 03/04/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.08 | 16.26 | 26.73 | 14.76 |